Cocrystal Pharma (COCP) Invested Capital (2010 - 2022)
Cocrystal Pharma (COCP) reported Invested Capital of $21000.0 for Q2 2022, down 61.11% on a YoY basis from $54000.0 in Q2 2021, and down 25.0% sequentially from $28000.0 in Q1 2022.
Cocrystal Pharma (COCP) Invested Capital (2010 - 2022) Analysis & Trends
Cocrystal Pharma (COCP) has 9 years of Invested Capital data on file, last reported at $21000.0 in Q2 2022.
- For the quarter ending Q2 2022, Invested Capital fell 61.11% year-over-year to $21000.0; the trailing twelve-month figure through Mar 2023 stood at $21000.0 (down 83.2% YoY), and the FY2020 full-year result was $74000.0, down 36.75% from the prior year.
- Invested Capital fell to $21000.0 in Q2 2022, from $28000.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $341000.0 in Q4 2018 to a low of $21000.0 in Q2 2022.
- A 5-year average of $118142.9 and a median of $79000.0 in 2020 frame the typical range for Invested Capital.
- Across the five-year window, Invested Capital slumped 78.49% in 2020 and rose 5.0% in 2021, its largest moves.
- Tracing COCP's Invested Capital over 5 years: stood at $341000.0 in 2018, then plunged by 65.69% to $117000.0 in 2019, then sank by 36.75% to $74000.0 in 2020, then slumped by 41.89% to $43000.0 in 2021, then tumbled by 51.16% to $21000.0 in 2022.
- Business Quant data shows COCP's Invested Capital at $21000.0 in Q2 2022, $28000.0 in Q1 2022, and $43000.0 in Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 110.96 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 116.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 21,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Sep 30, 2021 | 43,000.00 |
| Jun 30, 2021 | 54,000.00 |
| Mar 31, 2021 | 63,000.00 |
| Dec 31, 2020 | 74,000.00 |
| Sep 30, 2020 | 84,000.00 |
| Jun 30, 2020 | 93,000.00 |
| Mar 31, 2020 | 60,000.00 |
| Dec 31, 2019 | 117,000.00 |
| Sep 30, 2019 | 172,000.00 |
| Jun 30, 2019 | 225,000.00 |
| Mar 31, 2019 | 279,000.00 |
| Dec 31, 2018 | 341,000.00 |
| Jun 30, 2013 | 206,042.00 |
| Mar 31, 2013 | 206,040.00 |
| Dec 31, 2012 | 181,752.00 |
| Sep 30, 2012 | 194,247.00 |
| Jun 30, 2012 | 217,755.00 |
| Mar 31, 2012 | 241,149.00 |